These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 1980697

  • 21. Depression in panic disorder and response to alprazolam therapy.
    Pyke RE.
    Arch Gen Psychiatry; 1989 Nov; 46(11):1053-4. PubMed ID: 2818142
    [No Abstract] [Full Text] [Related]

  • 22. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE, Greenberg HS.
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [Abstract] [Full Text] [Related]

  • 23. Sequence of improvement in agoraphobia with panic attacks.
    Rifkin A, Pecknold JC, Swinson RP, Ballenger JC, Burrows GD, Noyes R, Dupont RL, Lesser I.
    J Psychiatr Res; 1990 Feb; 24(1):1-8. PubMed ID: 2195163
    [Abstract] [Full Text] [Related]

  • 24. Overview of the Cross-National Collaborative Panic Study.
    Klerman GL.
    Arch Gen Psychiatry; 1988 May; 45(5):407-12. PubMed ID: 3282477
    [Abstract] [Full Text] [Related]

  • 25. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R, Kahn RJ, McNair DM, Frankenthaler LM.
    Psychopharmacol Bull; 1986 May; 22(1):167-72. PubMed ID: 2873609
    [No Abstract] [Full Text] [Related]

  • 26. Panic disorder: response to sodium lactate and treatment with antidepressants.
    Rifkin A, Siris SG.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985 May; 9(1):33-8. PubMed ID: 3887490
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Andersch S, Rosenberg NK, Kullingsjö H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergård M, Rasmussen S.
    Acta Psychiatr Scand Suppl; 1991 May; 365():18-27. PubMed ID: 1862730
    [Abstract] [Full Text] [Related]

  • 28. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991 May; 365():46-52. PubMed ID: 1862734
    [Abstract] [Full Text] [Related]

  • 29. Panic attacks and agoraphobia: low dose clomipramine treatment.
    Gloger S, Grunhaus L, Gladic D, O'Ryan F, Cohen L, Codner S.
    J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
    [Abstract] [Full Text] [Related]

  • 30. Alprazolam in the treatment of social phobia.
    Lydiard RB, Laraia MT, Howell EF, Ballenger JC.
    J Clin Psychiatry; 1988 Jan; 49(1):17-9. PubMed ID: 3335485
    [Abstract] [Full Text] [Related]

  • 31. The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.
    Marks IM, De Albuquerque A, Cottraux J, Gentil V, Greist J, Hand I, Liberman RL, Relvas JS, Tobeña A, Tyrer P.
    Arch Gen Psychiatry; 1989 Jul; 46(7):668-72. PubMed ID: 2660772
    [No Abstract] [Full Text] [Related]

  • 32. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E, Rickels K, Weiss S, Zavodnick S.
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [Abstract] [Full Text] [Related]

  • 33. Lactate vulnerability after alprazolam versus placebo treatment of panic disorder.
    Cowley DS, Dager SR, Roy-Byrne PP, Avery DH, Dunner DL.
    Biol Psychiatry; 1991 Jul 01; 30(1):49-56. PubMed ID: 1892962
    [Abstract] [Full Text] [Related]

  • 34. Imipramine in the treatment of panic disorder and its complications.
    Liebowitz MR.
    Psychiatr Clin North Am; 1985 Mar 01; 8(1):37-47. PubMed ID: 3887338
    [Abstract] [Full Text] [Related]

  • 35. A review of the psychopharmacology of panic disorder: individual differences and non specific factors.
    Cox BJ, Swinson RP, Endler NS.
    Can J Psychiatry; 1991 Mar 01; 36(2):130-8. PubMed ID: 2044033
    [Abstract] [Full Text] [Related]

  • 36. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA, Argyle N, Klerman GL.
    J Clin Psychiatry; 1991 Mar 01; 52(3):121-7. PubMed ID: 2005075
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.
    Ciraulo DA, Barnhill JG, Boxenbaum HG, Greenblatt DJ, Smith RB.
    J Clin Pharmacol; 1986 Apr 01; 26(4):292-8. PubMed ID: 2871050
    [Abstract] [Full Text] [Related]

  • 38. Pharmacotherapeutic considerations in anxiety disorders.
    Hollister LE.
    J Clin Psychiatry; 1986 Jun 01; 47 Suppl():33-6. PubMed ID: 2872208
    [Abstract] [Full Text] [Related]

  • 39. Alprazolam levels and response in panic disorder: preliminary results.
    Wincor MZ, Munjack DJ, Palmer R.
    J Clin Psychopharmacol; 1991 Feb 01; 11(1):48-51. PubMed ID: 2040715
    [Abstract] [Full Text] [Related]

  • 40. Agoraphobia and panic disorder: treatment with alprazolam.
    Mark SL.
    Tex Med; 1984 Oct 01; 80(10):50-2. PubMed ID: 6150561
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.